At a glance
- Originator Pfizer
- Class Anti-inflammatories; Antineoplastics; Antiplatelets; Antipsoriatics; Small molecules
- Mechanism of Action Platelet-derived growth factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Atherosclerosis; Cancer; Coronary artery restenosis; Psoriasis
Most Recent Events
- 04 Feb 2002 No-Development-Reported for Atherosclerosis in USA (Unknown route)
- 04 Feb 2002 No-Development-Reported for Cancer in USA (Unknown route)
- 04 Feb 2002 No-Development-Reported for Coronary artery restenosis in USA (Unknown route)